InvestorsHub Logo
Followers 60
Posts 7400
Boards Moderated 0
Alias Born 10/20/2014

Re: Optionsrbest4u post# 298420

Friday, 09/11/2020 2:35:00 PM

Friday, September 11, 2020 2:35:00 PM

Post# of 426489
Optionsrbest4u, With the share price this low anything is possible
except for BP paying "full value" for AMRN. BP may believe they could
get $5 billion in peak sales from Europe alone. Will they make an offer
to reflect that? Not with the stock at $4.00. Perhaps a hostile bid
would ignite a bidding war for AMRN. The best way for Vascepa sales
to be optimized in Europe is for a BP to handle the launch.

Maybe JT is entertaining some interest. If there were no solid interest
now would be a time to hire an investment banking firm. I wonder if JT
could negotiate a way out of this skinny label mess with the FDA. JT is
the wrong person to have as CEO. Hope he has a mandate from the BOD
to sell the company. Imagine what the Baber Brothers have told him
after losing $800 million or so of their positions value..."Good job,
John, keep up the outstanding work!"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News